Table 2.
Type of cell | No. of experiments | Total No. of CB assessed | Cells/mouse | Proportion of negative mice |
---|---|---|---|---|
Light density | 3 | 7 | 3 × 106 | 2/10 |
1 × 106 | 2/8 | |||
8 × 105 | 0/6 | |||
3 × 105 | 3/8 | |||
2 × 105 | 1/6 | |||
5 × 104 | 3/4 | |||
CD34+CD38+ | 2 | 4 | 5 × 104 | 0/5 |
1.5 × 104 | 5/6 | |||
7,500 | 2/6 | |||
3,000 | 5/5 | |||
600 | 4/5 | |||
CD34+CD38− | 7 | 16 | 4,400 | 1/2 |
3,000 | 2/11 | |||
2,000 | 5/5 | |||
1,000 | 5/17 | |||
500 | 5/12 | |||
300 | 1/4 | |||
200 | 10/14 | |||
50 | 21/25 | |||
Cultured CD34+CD38− | 6 | 14 | 4,400 | 0/3 |
1,000 | 2/11 | |||
500 | 3/5 | |||
200 | 9/12 | |||
100 | 3/3 | |||
50 | 5/6 | |||
40 | 3/7 |
Negative mice were defined as those that did not contain detectable levels of both human CD34−CD19+ (B-lymphoid) and CD34+ CFC (myeloid) cells. Pooled data from the number of experiments shown (2 to 3 CB samples pooled per experiment).